We are live on ! Find out more
MCM

Mengis Capital Management Portfolio holdings

AUM $658M
1-Year Est. Return 39.64%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+39.64%
3 Year Est. Return
+91.78%
5 Year Est. Return
+129.93%
10 Year Est. Return
+407.15%
AUM
$493M
AUM Growth
-$155M
Cap. Flow
-$153M
Cap. Flow %
-30.92%
Top 10 Hldgs %
37.27%
Holding
223
New
7
Increased
24
Reduced
125
Closed
43

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$32.8M
2
PCAR icon
PACCAR
PCAR
+$31.9M
3
AAPL icon
Apple
AAPL
+$14.8M
4
COST icon
Costco
COST
+$9.57M
5
WWD icon
Woodward
WWD
+$4.96M

Sector Composition

Rank Sector Weight
1 Technology 23.06%
2 Industrials 16.94%
3 Healthcare 13.95%
4 Consumer Staples 9.16%
5 Energy 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
26
Philip Morris
PM
$295B
$4.53M 0.92%
44,704
-2,643
-6% -$258K
HSY icon
27
Hershey
HSY
$35.6B
$4.47M 0.91%
24,295
+1,865
+8% +$361K
ATI icon
28
ATI
ATI
$25.3B
$4.43M 0.9%
79,952
-450
-0.6% -$25.2K
BAC icon
29
Bank of America
BAC
$434B
$4.2M 0.85%
105,664
-17,662
-14% -$677K
SCHM icon
30
Schwab US Mid-Cap ETF
SCHM
$14.6B
$4.11M 0.83%
158,286
+591
+0.4% +$15.5K
BRK.B icon
31
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.96M 0.8%
9,746
-370
-4% -$151K
SPY icon
32
State Street SPDR S&P 500 ETF Trust
SPY
$786B
$3.95M 0.8%
7,260
-120
-2% -$62.8K
IBM icon
33
IBM
IBM
$210B
$3.84M 0.78%
22,182
-6,789
-23% -$1.18M
BRKR icon
34
Bruker
BRKR
$9.74B
$3.8M 0.77%
59,540
+2,850
+5% +$215K
KMB icon
35
Kimberly-Clark
KMB
$36.1B
$3.53M 0.72%
25,562
-1,000
-4% -$134K
A icon
36
Agilent Technologies
A
$38.7B
$3.51M 0.71%
27,040
-13,553
-33% -$1.9M
WWD icon
37
Woodward
WWD
$21.3B
$3.49M 0.71%
20,000
-29,137
-59% -$4.96M
PG icon
38
Procter & Gamble
PG
$332B
$3.21M 0.65%
19,442
-650
-3% -$106K
KO icon
39
Coca-Cola
KO
$376B
$3.19M 0.65%
50,188
-3,985
-7% -$247K
IAU icon
40
iShares Gold Trust
IAU
$62.5B
$3.19M 0.65%
72,623
-500
-0.7% -$22.1K
BMY icon
41
Bristol-Myers Squibb
BMY
$131B
$3.1M 0.63%
74,708
-7,224
-9% -$323K
GSLC icon
42
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15B
$3.08M 0.63%
28,844
+143
+0.5% +$14.8K
FDX icon
43
FedEx
FDX
$73B
$3.05M 0.62%
10,176
-419
-4% -$110K
KR icon
44
Kroger
KR
$35.1B
$3M 0.61%
60,045
-21,004
-26% -$1.13M
SPXC icon
45
SPX Corp
SPXC
$11.8B
$2.98M 0.61%
21,000
-9,000
-30% -$1.19M
SLB icon
46
SLB Ltd
SLB
$73.3B
$2.97M 0.6%
62,857
-199
-0.3% -$9.61K
ADP icon
47
Automatic Data Processing
ADP
$104B
$2.96M 0.6%
12,420
-3,300
-21% -$810K
CVS icon
48
CVS Health
CVS
$134B
$2.94M 0.6%
49,736
-4,273
-8% -$267K
SBUX icon
49
Starbucks
SBUX
$123B
$2.74M 0.55%
35,165
-40,100
-53% -$3.27M
BSV icon
50
Vanguard Short-Term Bond ETF
BSV
$44.6B
$2.59M 0.53%
33,831
+13
+0% +$992

Similar funds

Mengis Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Mengis Capital Management held 223 positions worth $493M, down 24% from $649M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Mengis Capital Management withdrew a net $153M in Q2 2024, closing 43 positions and reducing 125 holdings. Its most notable exit was St. Joe Company, an estimated $1.82M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Mengis Capital Management opened a new position in Air Products & Chemicals worth $575K.

  • Mengis Capital Management's largest Q2 2024 buy was Air Products & Chemicals: 2,228 shares worth $575K.
  • Mengis Capital Management added most to Medtronic in Q2 2024, an estimated $1.46M increase.
  • Mengis Capital Management's biggest Q2 2024 reduction was Microsoft, cutting an estimated $32.8M.
  • Mengis Capital Management fully exited St. Joe Company in Q2 2024, selling an estimated $1.82M.
  • Mengis Capital Management's ten largest holdings make up 37% of its $493M portfolio in Q2 2024.
  • Mengis Capital Management opened 7 new positions and closed 43 in Q2 2024.
  • Mengis Capital Management's portfolio value fell 24% quarter-over-quarter to $493M.

Based on Mengis Capital Management's 13F filing for Q2 2024, filed 17 Jul 2024.